Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event June 21, 2022, 11:06 UTC (99% Neutral) KARUNA THERAPEUTICS, INC. (KRTX) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 2, 2025, 8:25 a.m. 📋 KARUNA THERAPEUTICS, INC. (KRTX) - Regulatory Update Filing Date: 2022-06-21 Accepted: 2022-06-21 07:06:03 Event Type: Regulatory Update Event Details: Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Announces Regulatory Update Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024)CIK: 0001771917Ticker Symbol: KRTXPeriod End Date: 2022-06-15Document Type: 8-K
📋 KARUNA THERAPEUTICS, INC. (KRTX) - Regulatory Update
Filing Date: 2022-06-21
Accepted: 2022-06-21 07:06:03
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: